
    
      Between March 1, 2019, and December 31, 2020, a group of 300 well-nourished patients will be
      enrolled to the study and randomly assigned two one of two groups: A-high protein oral
      supplements (ONS) and B- immunomodulating ONS. The study is designed to test the hypothesis
      that immunonutrition and reduce the incidence of infectious complications after upper
      gastrointestinal surgery; the secondary objective of the study was to evaluate the effect of
      nutritional intervention on overall morbidity and mortality rates, and hospital stay.
    
  